# Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients

> **NCT04290429** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Freiburg** · enrollment: 6 (actual)

## Conditions studied

- Graft Versus Host Disease

## Interventions

- **DRUG:** Teduglutide

## Key facts

- **NCT ID:** NCT04290429
- **Lead sponsor:** University of Freiburg
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-06
- **Primary completion:** 2019-12-06
- **Final completion:** 2019-12-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04290429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04290429, "Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04290429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*